HEADER TRANSFERASE 08-FEB-23 7FU4 TITLE CRYSTAL STRUCTURE OF HUMAN CYCLIC GMP-AMP SYNTHASE IN COMPLEX WITH 2- TITLE 2 [(2-FLUORO-4-PHENYLPHENYL)METHYLAMINO]-5-PROPYL-4H-[1,2,4]TRIAZOLO[1, TITLE 3 5-A]PYRIMIDIN-7-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIC GMP-AMP SYNTHASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 161-522; COMPND 5 SYNONYM: CGAMP SYNTHASE,CGAS,H-CGAS,2'3'-CGAMP SYNTHASE,MAB-21 COMPND 6 DOMAIN-CONTAINING PROTEIN 1; COMPND 7 EC: 2.7.7.86; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CGAS, C6ORF150, MB21D1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21A_CGAS(161-522_WT) KEYWDS IMMUNE RESPONSE, TRANSFERASE, NTASE, DNA SENSOR EXPDTA X-RAY DIFFRACTION AUTHOR L.LEIBROCK,J.BENZ,K.GROEBKE-ZBINDEN,D.HUNZIKER,M.G.RUDOLPH REVDAT 1 21-FEB-24 7FU4 0 JRNL AUTH K.GROEBKE-ZBINDEN,A.VANDEMEULEBROUCKE,M.HILBERT,M.G.RUDOLPH JRNL TITL CRYSTAL STRUCTURE OF A HUMAN CYCLIC GMP-AMP SYNTHASE COMPLEX JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.93 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.15RC1_3423 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.93 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.54 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.0 REMARK 3 NUMBER OF REFLECTIONS : 30026 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.150 REMARK 3 FREE R VALUE TEST SET COUNT : 1547 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.5459 - 4.2826 1.00 3159 173 0.1745 0.2087 REMARK 3 2 4.2826 - 3.3997 1.00 2975 166 0.1918 0.2624 REMARK 3 3 3.3997 - 2.9700 1.00 2955 157 0.2236 0.2655 REMARK 3 4 2.9700 - 2.6985 1.00 2958 144 0.2450 0.2949 REMARK 3 5 2.6985 - 2.5051 1.00 2925 156 0.2361 0.2970 REMARK 3 6 2.5051 - 2.3574 1.00 2917 159 0.2410 0.3305 REMARK 3 7 2.3574 - 2.2394 1.00 2911 165 0.2488 0.3110 REMARK 3 8 2.2394 - 2.1419 1.00 2877 168 0.2689 0.3206 REMARK 3 9 2.1419 - 2.0594 0.90 2606 124 0.2970 0.3415 REMARK 3 10 2.0594 - 1.9884 0.63 1826 110 0.3097 0.3890 REMARK 3 11 1.9884 - 1.9262 0.13 370 25 0.2921 0.3697 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.310 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 58.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 72.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 161 THROUGH 198 ) REMARK 3 ORIGIN FOR THE GROUP (A): 33.4263 11.5801 25.1731 REMARK 3 T TENSOR REMARK 3 T11: 0.4653 T22: 0.7247 REMARK 3 T33: 0.4262 T12: -0.0119 REMARK 3 T13: 0.0874 T23: -0.0076 REMARK 3 L TENSOR REMARK 3 L11: 4.8017 L22: 6.4533 REMARK 3 L33: 2.6182 L12: 0.6891 REMARK 3 L13: 0.0312 L23: 0.0869 REMARK 3 S TENSOR REMARK 3 S11: -0.2838 S12: -0.9522 S13: -0.6394 REMARK 3 S21: 0.0191 S22: 0.0850 S23: -1.8076 REMARK 3 S31: -0.0270 S32: 0.6257 S33: 0.1556 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 199 THROUGH 272 ) REMARK 3 ORIGIN FOR THE GROUP (A): 14.4898 -0.7558 20.3243 REMARK 3 T TENSOR REMARK 3 T11: 0.4420 T22: 0.4826 REMARK 3 T33: 0.7023 T12: -0.0697 REMARK 3 T13: 0.1580 T23: 0.0671 REMARK 3 L TENSOR REMARK 3 L11: 4.2909 L22: 3.4644 REMARK 3 L33: 3.2117 L12: -1.7436 REMARK 3 L13: 0.4200 L23: 0.0131 REMARK 3 S TENSOR REMARK 3 S11: -0.2316 S12: 0.0222 S13: -1.3916 REMARK 3 S21: -0.4510 S22: 0.2002 S23: 0.0873 REMARK 3 S31: 0.3725 S32: -0.0359 S33: 0.0211 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 273 THROUGH 388 ) REMARK 3 ORIGIN FOR THE GROUP (A): 16.2958 4.4045 21.2153 REMARK 3 T TENSOR REMARK 3 T11: 0.3188 T22: 0.4608 REMARK 3 T33: 0.4313 T12: 0.0082 REMARK 3 T13: 0.0544 T23: 0.0550 REMARK 3 L TENSOR REMARK 3 L11: 4.9727 L22: 3.5003 REMARK 3 L33: 2.9443 L12: -0.3696 REMARK 3 L13: -0.4184 L23: -1.0708 REMARK 3 S TENSOR REMARK 3 S11: -0.1760 S12: -0.9014 S13: -0.9193 REMARK 3 S21: 0.2931 S22: 0.0505 S23: 0.1047 REMARK 3 S31: 0.2900 S32: -0.1044 S33: 0.0259 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 389 THROUGH 520 ) REMARK 3 ORIGIN FOR THE GROUP (A): 16.6259 26.4143 23.8433 REMARK 3 T TENSOR REMARK 3 T11: 0.4684 T22: 0.4007 REMARK 3 T33: 0.4288 T12: 0.0459 REMARK 3 T13: 0.0716 T23: -0.1629 REMARK 3 L TENSOR REMARK 3 L11: 2.7846 L22: 2.3965 REMARK 3 L33: 4.6369 L12: 0.1570 REMARK 3 L13: -0.1203 L23: 0.3257 REMARK 3 S TENSOR REMARK 3 S11: 0.2009 S12: -0.6641 S13: 0.6601 REMARK 3 S21: 0.4278 S22: 0.0283 S23: 0.0477 REMARK 3 S31: -0.7100 S32: -0.0356 S33: -0.2119 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: LIGAND WELL DEFINED BY ELECTRON DENSITY REMARK 4 REMARK 4 7FU4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1001405349. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-FEB-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000030 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE, XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34187 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.930 REMARK 200 RESOLUTION RANGE LOW (A) : 43.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.524 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.1200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.93 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.75 REMARK 200 R MERGE FOR SHELL (I) : 2.05000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.710 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: INHOUSE MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10-12 MG/ML PROTEIN IN 25 MM TRIS/HCL REMARK 280 PH7.5, 500MM NACL, 2MM TCEP, SUPPLEMENTED WITH 10X MOLAR EXCESS REMARK 280 OF LIGAND AND, IF NEEDED, WITH 10 MM MGCL2 AND 5MM ATP, THEN REMARK 280 MIXED 1:1 WITH RESERVOIR OF THE PROCOMPLEX SCREEN. SEVERAL REMARK 280 CONDITIONS RESULTED IN CRYSTALS., VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,-Y,-Z+1/2 REMARK 290 4555 -X+1/2,-Y,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 22.58550 REMARK 290 SMTRY2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.61650 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 22.58550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 81.61650 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 772 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 254 REMARK 465 ARG A 255 REMARK 465 ASN A 256 REMARK 465 PRO A 257 REMARK 465 LYS A 258 REMARK 465 GLU A 259 REMARK 465 LYS A 292 REMARK 465 ASP A 293 REMARK 465 THR A 294 REMARK 465 GLU A 366 REMARK 465 GLY A 367 REMARK 465 ASN A 368 REMARK 465 GLY A 369 REMARK 465 PHE A 370 REMARK 465 GLU A 521 REMARK 465 PHE A 522 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 371 CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 199 CA - CB - SG ANGL. DEV. = 6.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 199 50.91 -98.42 REMARK 500 THR A 211 38.01 -90.17 REMARK 500 ARG A 246 -31.49 72.87 REMARK 500 SER A 305 81.92 64.26 REMARK 500 SER A 313 -141.11 53.18 REMARK 500 SER A 345 154.19 100.80 REMARK 500 ASN A 389 73.87 -156.06 REMARK 500 ASN A 399 96.11 -69.67 REMARK 500 PHE A 516 75.14 41.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 601 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 390 NE2 REMARK 620 2 CYS A 396 SG 112.9 REMARK 620 3 CYS A 397 SG 108.6 126.0 REMARK 620 4 CYS A 404 SG 97.2 97.9 109.7 REMARK 620 N 1 2 3 DBREF 7FU4 A 161 522 UNP Q8N884 CGAS_HUMAN 161 522 SEQRES 1 A 362 GLY ALA SER LYS LEU ARG ALA VAL LEU GLU LYS LEU LYS SEQRES 2 A 362 LEU SER ARG ASP ASP ILE SER THR ALA ALA GLY MET VAL SEQRES 3 A 362 LYS GLY VAL VAL ASP HIS LEU LEU LEU ARG LEU LYS CYS SEQRES 4 A 362 ASP SER ALA PHE ARG GLY VAL GLY LEU LEU ASN THR GLY SEQRES 5 A 362 SER TYR TYR GLU HIS VAL LYS ILE SER ALA PRO ASN GLU SEQRES 6 A 362 PHE ASP VAL MET PHE LYS LEU GLU VAL PRO ARG ILE GLN SEQRES 7 A 362 LEU GLU GLU TYR SER ASN THR ARG ALA TYR TYR PHE VAL SEQRES 8 A 362 LYS PHE LYS ARG ASN PRO LYS GLU ASN PRO LEU SER GLN SEQRES 9 A 362 PHE LEU GLU GLY GLU ILE LEU SER ALA SER LYS MET LEU SEQRES 10 A 362 SER LYS PHE ARG LYS ILE ILE LYS GLU GLU ILE ASN ASP SEQRES 11 A 362 ILE LYS ASP THR ASP VAL ILE MET LYS ARG LYS ARG GLY SEQRES 12 A 362 GLY SER PRO ALA VAL THR LEU LEU ILE SER GLU LYS ILE SEQRES 13 A 362 SER VAL ASP ILE THR LEU ALA LEU GLU SER LYS SER SER SEQRES 14 A 362 TRP PRO ALA SER THR GLN GLU GLY LEU ARG ILE GLN ASN SEQRES 15 A 362 TRP LEU SER ALA LYS VAL ARG LYS GLN LEU ARG LEU LYS SEQRES 16 A 362 PRO PHE TYR LEU VAL PRO LYS HIS ALA LYS GLU GLY ASN SEQRES 17 A 362 GLY PHE GLN GLU GLU THR TRP ARG LEU SER PHE SER HIS SEQRES 18 A 362 ILE GLU LYS GLU ILE LEU ASN ASN HIS GLY LYS SER LYS SEQRES 19 A 362 THR CYS CYS GLU ASN LYS GLU GLU LYS CYS CYS ARG LYS SEQRES 20 A 362 ASP CYS LEU LYS LEU MET LYS TYR LEU LEU GLU GLN LEU SEQRES 21 A 362 LYS GLU ARG PHE LYS ASP LYS LYS HIS LEU ASP LYS PHE SEQRES 22 A 362 SER SER TYR HIS VAL LYS THR ALA PHE PHE HIS VAL CYS SEQRES 23 A 362 THR GLN ASN PRO GLN ASP SER GLN TRP ASP ARG LYS ASP SEQRES 24 A 362 LEU GLY LEU CYS PHE ASP ASN CYS VAL THR TYR PHE LEU SEQRES 25 A 362 GLN CYS LEU ARG THR GLU LYS LEU GLU ASN TYR PHE ILE SEQRES 26 A 362 PRO GLU PHE ASN LEU PHE SER SER ASN LEU ILE ASP LYS SEQRES 27 A 362 ARG SER LYS GLU PHE LEU THR LYS GLN ILE GLU TYR GLU SEQRES 28 A 362 ARG ASN ASN GLU PHE PRO VAL PHE ASP GLU PHE HET ZN A 601 1 HET YMO A 602 28 HETNAM ZN ZINC ION HETNAM YMO (8S)-2-{[(3-FLUORO[1,1'-BIPHENYL]-4-YL)METHYL]AMINO}-5- HETNAM 2 YMO PROPYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7(4H)-ONE FORMUL 2 ZN ZN 2+ FORMUL 3 YMO C21 H20 F N5 O FORMUL 4 HOH *77(H2 O) HELIX 1 AA1 ALA A 162 ASP A 178 1 17 HELIX 2 AA2 THR A 181 CYS A 199 1 19 HELIX 3 AA3 ASN A 260 GLN A 264 5 5 HELIX 4 AA4 SER A 272 ASN A 289 1 18 HELIX 5 AA5 PRO A 331 GLN A 335 5 5 HELIX 6 AA6 SER A 345 LEU A 354 1 10 HELIX 7 AA7 PHE A 379 ASN A 388 1 10 HELIX 8 AA8 CYS A 405 PHE A 424 1 20 HELIX 9 AA9 SER A 434 ASN A 449 1 16 HELIX 10 AB1 GLN A 451 LYS A 458 5 8 HELIX 11 AB2 ASP A 459 GLU A 478 1 20 HELIX 12 AB3 ASP A 497 ASN A 514 1 18 HELIX 13 AB4 GLU A 515 ASP A 520 5 6 SHEET 1 AA1 7 VAL A 206 LEU A 208 0 SHEET 2 AA1 7 GLU A 225 GLU A 233 -1 O LYS A 231 N GLY A 207 SHEET 3 AA1 7 ILE A 316 SER A 326 1 O THR A 321 N PHE A 230 SHEET 4 AA1 7 PHE A 357 PRO A 361 -1 O LEU A 359 N LEU A 324 SHEET 5 AA1 7 TRP A 375 SER A 378 -1 O ARG A 376 N VAL A 360 SHEET 6 AA1 7 TYR A 248 LYS A 252 -1 N TYR A 249 O TRP A 375 SHEET 7 AA1 7 GLN A 238 GLU A 241 -1 N GLN A 238 O LYS A 252 SHEET 1 AA2 5 VAL A 206 LEU A 208 0 SHEET 2 AA2 5 GLU A 225 GLU A 233 -1 O LYS A 231 N GLY A 207 SHEET 3 AA2 5 ILE A 316 SER A 326 1 O THR A 321 N PHE A 230 SHEET 4 AA2 5 VAL A 308 ILE A 312 -1 N ILE A 312 O ILE A 316 SHEET 5 AA2 5 VAL A 296 LYS A 299 -1 N ILE A 297 O LEU A 311 SHEET 1 AA3 2 LEU A 266 GLU A 267 0 SHEET 2 AA3 2 ILE A 270 LEU A 271 -1 O ILE A 270 N GLU A 267 LINK NE2 HIS A 390 ZN ZN A 601 1555 1555 2.11 LINK SG CYS A 396 ZN ZN A 601 1555 1555 2.30 LINK SG CYS A 397 ZN ZN A 601 1555 1555 2.21 LINK SG CYS A 404 ZN ZN A 601 1555 1555 2.40 CISPEP 1 SER A 305 PRO A 306 0 -4.25 CRYST1 45.171 59.343 163.233 90.00 90.00 90.00 P 21 2 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022138 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016851 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006126 0.00000